Diagnostic and economic evaluation of new biomarkers for Alzheimer’s disease: the research protocol of a prospective cohort study

Diagnostic and economic evaluation of new biomarkers for Alzheimer’s disease: the research protocol of a prospective cohort study

<p>Abstract</p> <p>Background</p> <p>New research criteria for the diagnosis of Alzheimer’s disease (AD) have recently been developed to enable an early diagnosis of AD pathophysiology by relying on emerging biomarkers. To enable efficient allocation of health care reso...

Full description

Bibliographic Details
Main Authors:	Handels Ron LH, Aalten Pauline, Wolfs Claire AG, OldeRikkert Marcel, Scheltens Philip, Visser Pieter, Joore Manuela A, Severens Johan L, Verhey Frans RJ
Format:	Article
Language:	English
Published:	BMC 2012-08-01
Series:	BMC Neurology
Online Access:	http://www.biomedcentral.com/1471-2377/12/72

Similar Items

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.
by: Stephanie J B Vos, et al.
Published: (2014-01-01)

Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
by: Verhey Frans RJ, et al.
Published: (2007-06-01)

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports
by: Diane Slats, et al.
Published: (2010-02-01)

Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease
by: Alexandra König, et al.
Published: (2015-03-01)

Pre-trained MRI-based Alzheimer's disease classification models to classify memory clinic patients
by: Frank de Vos, et al.
Published: (2020-01-01)

Cost-effectiveness of one year dementia follow-up care by memory clinics or general practitioners: economic evaluation of a randomised controlled trial.
by: Els Meeuwsen, et al.
Published: (2013-01-01)

The effects of involving a nurse practitioner in primary care for adult patients with urinary incontinence: <it>The PromoCon study (Promoting Continence)</it>
by: Severens Johan, et al.
Published: (2008-04-01)

Memory for Emotional Pictures in Patients with Alzheimer's Dementia: Comparing Picture-Location Binding and Subsequent Recognition
by: Marloes J. Huijbers, et al.
Published: (2011-01-01)

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
by: Isabelle Bos, et al.
Published: (2018-06-01)

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
by: Isabelle Bos, et al.
Published: (2017-12-01)

Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional 31P MR spectroscopic imaging study
by: Anne Rijpma, et al.
Published: (2018-01-01)

Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: results of a randomised controlled trial
by: Wouters Emiel FM, et al.
Published: (2007-07-01)

A new combined strategy to implement a community occupational therapy intervention: designing a cluster randomized controlled trial
by: Adang Eddy, et al.
Published: (2011-03-01)

Comorbidity and progression of late onset Alzheimer's disease: A systematic review.
by: Miriam L Haaksma, et al.
Published: (2017-01-01)

Dutch GPs’ experience of burden by euthanasia requests from people with dementia: a quantitative survey
by: Jaap Schuurmans, et al.
Published: (2021-01-01)

Early warning signals for critical transitions in cardiopulmonary health, related to air pollution in an urban Chinese population
by: Ce Wang, et al.
Published: (2018-12-01)

Rerouting Geriatric Medicine by Complementing Static Frailty Measures With Dynamic Resilience Indicators of Recovery Potential
by: Marcel G. M. Olde Rikkert, et al.
Published: (2019-06-01)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?
by: Gayatri Devi, et al.
Published: (2018-12-01)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
by: Elles Konijnenberg, et al.
Published: (2020-05-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
by: Betty Marije Tijms, et al.
Published: (2021-08-01)

The art of simulation
by: Anders Wimo, et al.
Published: (2020-10-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
by: Rosha Babapour Mofrad, et al.
Published: (2019-12-01)

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
by: Douglas Galasko, et al.
Published: (2020-05-01)

The role of Information and Communication Technologies in clinical trials with patients with Alzheimer’s disease and related disorders
by: Alexandra eKönig, et al.
Published: (2015-06-01)

The “rights” of precision drug development for Alzheimer’s disease
by: Jeffrey Cummings, et al.
Published: (2019-08-01)

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease
by: Ellen Dicks, et al.
Published: (2019-01-01)

The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer’s disease: results from a randomized controlled trial
by: Anne Rijpma, et al.
Published: (2017-07-01)

Pre‐amyloid stage of Alzheimer's disease in cognitively normal individuals
by: Betty M. Tijms, et al.
Published: (2018-09-01)

Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis
by: Marie Westwood, et al.
Published: (2014-05-01)

ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis
by: Marie Westwood, et al.
Published: (2016-09-01)

Development and pilot testing of quality improvement indicators for integrated primary dementia care
by: Marcel G M Olde Rikkert, et al.
Published: (2020-06-01)

Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis
by: Marie Westwood, et al.
Published: (2015-11-01)

Goal setting is insufficiently recognised as an essential part of shared decision-making in the complex care of older patients: a framework analysis
by: Neeltje Vermunt, et al.
Published: (2019-06-01)

High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis
by: Marie Westwood, et al.
Published: (2015-06-01)

KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
by: Marie Westwood, et al.
Published: (2014-10-01)

Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort.
by: Lyzel S Elias-Sonnenschein, et al.
Published: (2013-01-01)

Does a joint development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a pre/post study with concurrent control group and a randomised trial
by: Winkens Ron AG, et al.
Published: (2006-11-01)

The predictive value of normal EEGs in dementia due to Alzheimer’s disease
by: Casper T. Briels, et al.
Published: (2021-05-01)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
by: Hoogveldt B, et al.
Published: (2011-06-01)

Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts
by: Flora H. Duits, et al.
Published: (2021-01-01)